Zobrazeno 1 - 10
of 6 872
pro vyhledávání: '"van der Vliet"'
Autor:
van der Vliet, Nina, Den Broeder, Lea, Romeo-Velilla, María, Kruize, Hanneke, Staatsen, Brigit, Schuit, Jantine
Publikováno v:
JMIR Research Protocols, Vol 9, Iss 6, p e17323 (2020)
BackgroundThe INHERIT (INtersectoral Health and Environment Research for InnovaTion) project has evaluated intersectoral cooperation (IC) in 12 European case studies attempting to promote health, environmental sustainability, and equity through behav
Externí odkaz:
https://doaj.org/article/89ce8b12ad334cbfb2522883f7e9b6bf
Autor:
Yam, W. K., Renger, M., Gandorfer, S., Fesquet, F., Handschuh, M., Honasoge, K. E., Kronowetter, F., Nojiri, Y., Partanen, M., Pfeiffer, M., van der Vliet, H., Matthews, A. J., Govenius, J., Jabdaraghi, R. N., Prunnila, M., Marx, A., Deppe, F., Gross, R., Fedorov, K. G.
Scalable quantum information processing with superconducting circuits is expected to advance from individual processors located in single dilution refrigerators to more powerful distributed quantum computing systems. The realization of hardware platf
Externí odkaz:
http://arxiv.org/abs/2308.12398
Autor:
Lisa A. King, Myrthe Veth, Victoria Iglesias-Guimarais, Iris Blijdorp, Jan Kloosterman, André N. Vis, Rob C. Roovers, David Lutje Hulsik, Thilo Riedl, Anton E.P. Adang, Paul W.H.I. Parren, Pauline M. van Helden, Tanja D. de Gruijl, Hans J. van der Vliet
Publikováno v:
iScience, Vol 27, Iss 12, Pp 111289- (2024)
Summary: Vγ9Vδ2 T cells constitute a homogeneous effector T cell population that lyses tumors of different origin, including the prostate. We generated a bispecific T cell engager (bsTCE) to direct Vγ9Vδ2 T cells to PSMA+ prostate cancer (PCa) ce
Externí odkaz:
https://doaj.org/article/3851d95388e04a9c8291c66dc23ead05
Autor:
E. Michielon, L.A. King, T. Waaijman, M. Veth, S.W. Spiekstra, H.J. van der Vliet, S. Gibbs, T.D. de Gruijl
Publikováno v:
Immuno-Oncology and Technology, Vol 24, Iss , Pp 100724- (2024)
Background: Despite considerable advancements in cancer immunotherapy, advanced melanoma still presents a substantial clinical challenge. In an effort to explore treatment options, we examined the immunotherapeutic potential of effector Vγ9Vδ2-T ce
Externí odkaz:
https://doaj.org/article/cea97daa7da8476dbbb245152c597cf7
Autor:
Lotte Bakkerus, Beatriz Subtil, Hetty J. Bontkes, Elske C. Gootjes, Martine Reijm, Manon Vullings, Kiek Verrijp, John-Melle Bokhorst, Carmen Woortman, Iris D. Nagtegaal, Marianne A. Jonker, Hans J. van der Vliet, Cornelis Verhoef, Mark A.J. Gorris, I. Jolanda M. de Vries, Tanja D. de Gruijl, Henk M.W. Verheul, Tineke E. Buffart, Daniele V. F. Tauriello
Publikováno v:
OncoImmunology, Vol 13, Iss 1 (2024)
Colorectal cancer (CRC) raises considerable clinical challenges, including a high mortality rate once the tumor spreads to distant sites. At this advanced stage, more accurate prediction of prognosis and treatment outcome is urgently needed. The role
Externí odkaz:
https://doaj.org/article/d840e76947914521ba035fcfccc6eb05